Dexmedetomidine Hydrochloride Injection, Solution, Concentrate
Product Images NDC 36000-262

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine Hydrochloride (NDC 36000-262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-3 (Carton 3)

This is a description of Dexmedetomidine Injection, USP manufactured by Baxter Pharmaceuticals India Private Ltd and Baxter Healthcare Corporation. The injection is preservative-free and comes in 5 x 2 mL single-dose vials, with each vial containing 200 mcg/2 mL. It is for intravenous use and must be diluted before administration. The NDC number for this product is 36000-262-05.*

FDA Label Image

Carton-4 (Carton 4)

This is a description of a pharmaceutical product - Dexmedetomidine Injection, USP. The text mentions important information such as dosage (200 mcg/2 mL), administration (intravenous use), dilution instructions, manufacturer details (Baxter Pharmaceuticals India Private Ltd and Baxter Healthcare Corporation), and prescription details (Rx Only). The product comes in 10 x 2 mL Single-Dose Vials and is preservative-free.*

FDA Label Image

Carton-5 (Carton 5)

This text describes a pharmaceutical product named Dexmedetomidine Injection, USP. Each mL contains 118 mcg of Dexmedetomidine Hydrochloride USP equivalent to 100 mcg of Dexmedetomidine, along with Sodium Chloride and Water for Injection. The solution is preservative-free and should be stored at 20°C to 25°C. The product should not be used if discolored or if precipitate matter is present. The package insert should be consulted for the usual dosage. The product is intended for intravenous use and comes in single-dose vials. It is manufactured by Baxter Pharmaceuticals India Private Ltd.*

FDA Label Image

Container-2 (Container 2)

This text provides information about a medication called Dexmedetomidine in the form of an injection in a 2 mL single-dose vial. It contains 200 micrograms per 2 mL (100 mcg/mL) and is for intravenous use. The medication should be diluted before use, and any unused portion must be discarded. The text also mentions that the usual dosage information can be found in the package insert. The medication is made in India and manufactured for Baxter Healthcare Corporation in the USA. The revision date of the information is February 19, 2025.*

FDA Label Image

Description-1 (Description 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.